Qingfeng Pharmaceutcial Group's Shikang® Apixaban was approved by NMPA

964

Issuing time:2020-05-21 00:00

On May 12, the National Medical Products Administration (NMPA) formally approved the application of Shikang® Apixaban tablets from Jiangxi Qingfeng Pharmaceutical.

┃ Shikang® Apixaban tablets

PrevMr. Li Bingjun visited the company to guide the resumption of work and production

NextYao Zengke, Chairman of the Provincial Committee of the Chinese People's Political Consultative Conf

Article classification: Company News

Share to：

Qingfeng Pharmaceutical Group Co.Ltd

Location：8 Zhandong Av., Zhanggong, Ganzhou, Jiangxi Province, China

Phone：+86-0797-5560800,5560600 Fax: +86-0797-5560620